BP Directors, LP insider trades
BP Directors, LP has filed 6 Form 4s with the SEC that we hold, for Lantern Pharma Inc. (LTRN) (10% owner), Actuate Therapeutics, INC. (ACTU) (Director, 10% owner) and In8Bio, INC. (INAB) (10% owner). Across all of them we count 2 purchases worth $4.0M and 22 sales worth $1.3M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 375,000 shares of Actuate Therapeutics, INC. worth $3.0M, dated 2024-08-14. The first filing on our record is dated 2022-09-07 and the latest 2025-06-13.
Lantern Pharma Inc. (LTRN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-09-02 | S, sale reported on Form 4 | 5,170 | $26.9K | 2022-09-07 |
| 2022-09-02 | S, sale reported on Form 4 | 1,275 | $6.6K | 2022-09-07 |
| 2024-01-17 | S, sale reported on Form 4 | 12,521 | $52.6K | 2024-01-19 |
| 2024-01-17 | S, sale reported on Form 4 | 5,475 | $23.0K | 2024-01-19 |
| 2024-01-17 | S, sale reported on Form 4 | 40,893 | $171.8K | 2024-01-19 |
| 2024-02-27 | S, sale reported on Form 4 | 34,731 | $152.8K | 2024-02-29 |
| 2024-02-27 | S, sale reported on Form 4 | 10,620 | $46.7K | 2024-02-29 |
| 2024-02-27 | S, sale reported on Form 4 | 4,649 | $20.5K | 2024-02-29 |
| 2024-02-28 | S, sale reported on Form 4 | 15,780 | $76.5K | 2024-02-29 |
| 2024-02-28 | S, sale reported on Form 4 | 6,909 | $33.5K | 2024-02-29 |
| 2024-02-28 | S, sale reported on Form 4 | 51,608 | $250.3K | 2024-02-29 |
| 2024-02-29 | S, sale reported on Form 4 | 13,686 | $66.7K | 2024-02-29 |
| 2024-02-29 | S, sale reported on Form 4 | 4,185 | $20.4K | 2024-02-29 |
| 2024-02-29 | S, sale reported on Form 4 | 1,832 | $8.9K | 2024-02-29 |
| 2025-06-13 | S, sale reported on Form 4 | 14,218 | $43.9K | 2025-06-13 |
| 2025-06-13 | S, sale reported on Form 4 | 12,319 | $38.1K | 2025-06-13 |
| 2025-06-13 | S, sale reported on Form 4 | 4,354 | $13.5K | 2025-06-13 |
| 2025-06-13 | S, sale reported on Form 4 | 1,903 | $5.9K | 2025-06-13 |
| 2025-06-13 | S, sale reported on Form 4 | 7,206 | $22.3K | 2025-06-13 |
Actuate Therapeutics, INC. (ACTU)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-08-14 | S, sale reported on Form 4 | 5,314 | $47.8K | 2024-08-14 |
| 2024-08-14 | S, sale reported on Form 4 | 17,361 | $156.2K | 2024-08-14 |
| 2024-08-14 | S, sale reported on Form 4 | 2,324 | $20.9K | 2024-08-14 |
| 2024-08-14 | P, purchase reported on Form 4 | 375,000 | $3.0M | 2024-08-14 |
| 2024-08-14 | P, purchase reported on Form 4 | 125,000 | $1.0M | 2024-08-14 |
In8Bio, INC. (INAB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1813311) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms